A 2021 RAND Corporation analysis found that U.S
However, further research is needed to evaluate the long-term safety and efficacy of GLP-1RA
Approximately five of the 19 peptides are expected to remain on the Category 2 list due to more significant safety concerns or weaker human evidence
Clinically, motilin receptors have become therapeutic targets for prokinetic agents, particularly motilides such as erythromycin, though long-term efficacy is limited by receptor desensitization
doi: 10.1016/j.pharmthera.2005.05.002 211 ChaudhriAXiaoYKleeANWangXZhuBFreemanGJ
The peptide accelerates biological healing, but complete recovery requires addressing biomechanical factors, building strength, and optimizing the environment for tissue repair